Back to search

France· FR:62749394

FINACEA 15 %, gel

A medicinal product containing acide azélaïque, registered in France by LEO PHARMA A/S (DANEMARK).

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedFINACEA 15 %, gelATC—REGISTER NO.FR:62749394PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ACIDE AZÉLAÏQUE
Manufacturer
LEO PHARMA A/S (DANEMARK)
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400936244450
    1 tube(s) aluminium verni de 30 g

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Acide azélaïque in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acide azélaïque products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Finacea, Skinoren
  • Belgium · Skinoren
  • Bulgaria · Скинорен, Финацеа
  • Cyprus · Skinoren
  • Czechia · Skinoren
  • Germany · Skinoren
  • Denmark · Finacea, Skinoren
  • Estonia · Finacea, Skinoren
  • Spain · Finacea, Zeliderm
  • Finland · Skinoren
  • United Kingdom (Northern Ireland) · Finacea, Skinoren
  • Greece · Arbonid, Azelderm
  • Croatia · Skinoren
  • Hungary · Finacea, Skinoren
  • Ireland · Skinoren
  • Italy · Finacea, Skinoren
  • Lithuania · Finacea, Skinoren
  • Luxembourg · Skinoren
  • Latvia · Finacea, Skinoren
  • Norway · Finacea, Skinoren
  • Poland · Skinoren, Skinoren Rosacea
  • Portugal · Skinoren
  • Romania · Skinoren
  • Sweden · Azelainsyra Evolan, Finacea
  • Slovenia · Skinoren
  • Slovakia · Finacea, Skinoren

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/53c1ee63-864e-4b13-a71e-e66aa1f10c86
GET /v1/drugs/53c1ee63-864e-4b13-a71e-e66aa1f10c86?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62749394",
  "date_amm": "2003-06-11",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "ACIDE AZÉLAÏQUE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gel",
  "voies_administration": "cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about acide azélaïque.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.